TrialBone marrow transplantation2026
Excellent outcomes using a novel reduced intensity conditioning with thiotepa and post-transplant cyclophosphamide for HLA-matched related donor transplant in adolescents and adults with sickle cell disease.
Reem Alasbali et al.PubMed ↗Publisher ↗
No numbers read from the abstract.